Skip to content

Coagulation improvement after platelet transfusion in critically ill patients

Coagulation improvement after platelet transfusion in critically ill patients - Captain

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44365
Enrollment
24
Registered
2017-11-28
Start date
2018-05-08
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

low platelet count Thrombocytopenia

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients need to be admitted to the Intensive Care Unit • The indication for 1 unit of PLT concentrate, at physician*s discretion. • Arterial line to enable blood sampling.

Exclusion criteria

Exclusion criteria: • Contra-indication for PLT transfusion, e.g. TTP. • The use of ticagrelor or clopidogrel. • Severe active bleeding, e.g. bleeding that leads to multiple transfusions. • No informed consent

Design outcomes

Primary

MeasureTime frame
The increase in platelet count and the effect on coagulation before and after platelet concentrate transfusion.

Secondary

MeasureTime frame
Platelet increment at 2 and 4 hours • Rotational tromboelastography (INTEM, EXTEM, FIBTEM) • MCF, CT, CFT, a-Angle. • Classical coagulation tests • PT, INR, aPTT • Fibrinogen • D-Dimer • Multiplate • AUC, slope. • Trombin-antitrombin complexes • Trombin generation • Endothelial activation • Syndecan • Fragmentocytes

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)